RESEARCH HIGHLIGHTS
Cancer biology Sabotaging cellular stability
Viruses clear the way for cancer by promoting the destruction of cell adhesion regulators
Human papillomavirus (HPV) is known to be the primary causative agent for cervical cancer. The virus exerts its harmful effects by expressing a cohort of proteins — most notably E6 and E7 — to actively sabotage the host cell’s regulatory machin- ery. The disruption may affect numerous pathways involved in cellular growth and division. Françoise Thierry and co-workers at the A*STAR Institute
of Medical Biology’s Papillomavirus Regulation and Cancer research group have now found that HPV also causes tightly-anchored cells to become unmoored from their envi- ronment as a prelude to tumor growth. The researchers have identified the cellular protein p63 (also known as transforma- tion-related protein 63) as a key factor in this process1
.
“Many cellular genes belonging to adhesion pathways are modulated in cervical carcinoma cells expressing the E6 and E7 HPV oncogenes,” says Thierry. However, p63 is a complex target. The gene encoding p63 can
produce not one but six different variants (isoforms) of the same protein that differ in size and structure. Some isoforms have an activation domain at one end (TA), while others (∆N) lack this domain. Although the functions of these isoforms have not been fully elaborated, previous studies have linked ∆Np63α to certain skin cancers. Thierry and her colleagues worked with Caski cells, a cervical
cancer-derived epithelial cell line that expresses HPV E6 and E7. The researchers identified hundreds of genes whose expression was modified by E6 or E7, 123 of which were likely targets of p63 regulation. Significantly, many of these genes are known to contribute to cellular adhesion. This finding came as a surprise because the effect appeared to be mediated by the TAp63β isoform. “Based on previously published work, we expected that one of the ∆Np63 isoforms would be the major player in the epithe- lium rather than TAp63,” says Thierry. In subsequent experiments, Thierry and her research group
demonstrated that overexpression of TAp63β in Caski cells counteracted the abnormal gene regulation associated with E6/E7 expression. The researchers also learned that E6 in
A*STAR RESEARCH OCTOBER 2011– MARCH 2012 47
TAp63β-mediated focal adhesion in Caski cells, with the focal adhe- sion protein vinculin (an actin-binding protein frequently used as a marker for focal adhesion complexes in many types of cells) in red and DNA in blue
particular induces accelerated degradation of TAp63β, leading to reduced adhesion. Conversely, overexpression of TAp63β in cervical cancer cells results in increased formation of dense cellular clusters called focal adhesions, with elevated production of key adhesion proteins (see image). Thierry and her team plan to use this work as a springboard
to further explore the relative contributions of the various p63 isoforms in normal epithelial function, and to examine the role of TAp63β in tumor development. “We would like to demonstrate that TAp63 is expressed in tumor stem cells in our system and that its regulation by E6 is an essential step in neoplastic progression,” says Thierry. ■
1. Ben Khalifa, Y. et al. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation. PLoS Pathogens 7, e1002256 (2011).
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96